Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Genital Diseases, Kennedy disease, Male Urogenital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Urogenital Diseases, Urogenital Neoplasms, X-linked disease, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, male reproductive organ cancer, male reproductive system disorder, motor neuron disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, prostate cancer, prostate disorder, spinal cord disorder, spinal muscular atrophyRecruitingPhase 32026-10-05NCT07723248

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bayer178
ORIC Pharmaceuticals4

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BRCR Global (Network)San JuanPuerto Rico1
Cancer And Hematology Centers Of Western MichiganHollandUnited States1
Carolina Urologic Research CenterMyrtle BeachUnited States55
First Urology PSCJeffersonvilleUnited States1
Gabrail Cancer Center ResearchCantonUnited States26
Houston Metro Urology (HMU)HoustonUnited States1
SSAK Partners, LLCCoral SpringsUnited States1
Summit UrologyMurrayUnited States3
Urology AssociatesNashvilleUnited States10
Urology Clinics Of North TexasDallasUnited States16
Urology Partners of North Texas (UPNT)Fort WorthUnited States1
Urology Specialists of the Carolinas - University PlaceCharlotteUnited States1